Chicago Partners Investment Group LLC Boosts Stock Position in The Cooper Companies, Inc. $COO

Chicago Partners Investment Group LLC grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 297.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,250 shares of the medical device company’s stock after purchasing an additional 7,672 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in Cooper Companies were worth $686,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after acquiring an additional 7,363 shares during the period. First Trust Advisors LP boosted its stake in shares of Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after purchasing an additional 73,165 shares during the period. Cresset Asset Management LLC bought a new position in shares of Cooper Companies in the second quarter worth approximately $291,000. Cerity Partners LLC grew its holdings in shares of Cooper Companies by 4.4% in the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock worth $1,272,000 after purchasing an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its stake in shares of Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after buying an additional 973 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 1.9%

COO stock opened at $71.71 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company has a market capitalization of $13.99 billion, a price-to-earnings ratio of 60.77, a price-to-earnings-growth ratio of 1.91 and a beta of 0.84. The business’s 50 day moving average price is $66.24 and its two-hundred day moving average price is $72.58. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Analyst Ratings Changes

COO has been the subject of several analyst reports. Piper Sandler set a $86.00 price target on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. BNP Paribas Exane cut their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Citigroup reissued a “neutral” rating and set a $76.00 target price (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research note on Wednesday, May 27th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, Cooper Companies currently has an average rating of “Hold” and an average target price of $81.85.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.